Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Supernus Pharmaceuticals, Inc. SUPN NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
69/100
5/7 Pass
SharesGrow Intrinsic Value
$143.04
+185.5%
Analyst Price Target
$61.67
+23.1%

Supernus Pharmaceuticals, Inc. (SUPN) has 11 identified peers for comparison in the Healthcare sector. Peers include ANIP, COLL, DCPH, EGRX, EVO, PAHC and others.

SUPN has a market capitalization of $2.89B, compared to an average peer market cap of $3.48B.

People Also View

RGC
RGC
Regencell Bioscience Holdings Limited
$30.11
-6.61%
 RDY
RDY
Dr. Reddy's Laboratories Limited
$13.13
-1.06%
 PBH
PBH
Prestige Consumer Healthcare Inc.
$56.66
-0.32%
 PAHC
PAHC
Phibro Animal Health Corporation
$59.02
-0.94%
 DCPH
DCPH
Deciphera Pharmaceuticals, Inc.
$25.59
+0.08%
 ANIP
ANIP
ANI Pharmaceuticals, Inc.
$78.29
-0.03%
 COLL
COLL
Collegium Pharmaceutical, Inc.
$35.64
+0.06%
 EVO
EVO
Evotec SE
$3.12
+12.23%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message